0001209191-21-070631.txt : 20211220 0001209191-21-070631.hdr.sgml : 20211220 20211220180027 ACCESSION NUMBER: 0001209191-21-070631 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20211216 FILED AS OF DATE: 20211220 DATE AS OF CHANGE: 20211220 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Larson Tina Marriott CENTRAL INDEX KEY: 0001856414 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40323 FILM NUMBER: 211506310 MAIL ADDRESS: STREET 1: C/O RECURSION PHARMACEUTICALS STREET 2: 41 S. RIO GRANDE STREET CITY: SALT LAKE CITY STATE: UT ZIP: 84101 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: RECURSION PHARMACEUTICALS, INC. CENTRAL INDEX KEY: 0001601830 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 464099738 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 41S RIO GRANDE STREET CITY: SALT LAKE CITY STATE: UT ZIP: 84101 BUSINESS PHONE: (385) 269-0203 MAIL ADDRESS: STREET 1: 41S RIO GRANDE STREET CITY: SALT LAKE CITY STATE: UT ZIP: 84101 FORMER COMPANY: FORMER CONFORMED NAME: Recursion Pharmaceuticals, LLC DATE OF NAME CHANGE: 20140305 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2021-12-16 0 0001601830 RECURSION PHARMACEUTICALS, INC. RXRX 0001856414 Larson Tina Marriott 41 S. RIO GRANDE STREET SALT LAKE CITY UT 84101 0 1 0 0 President and COO Class A Common Stock 2021-12-16 4 S 0 1160 18.0884 D 48840 D Class A Common Stock 2021-12-16 4 S 0 1040 19.1662 D 47800 D Class A Common Stock 2021-12-16 4 S 0 300 19.7767 D 47500 D Sales are pursuant to a 10b5-1 trading plan established by the Reporting Person. The sales price reported herein is a weighted average price. These shares were sold in multiple lots at prices ranging from $17.63 to $18.53 per share. Full sale price information for each lot is available to the Issuer's stockholders and the staff of the U.S. Securities and Exchange Commission upon their written request. The sales price reported herein is a weighted average price. These shares were sold in multiple lots at prices ranging from $18.69 to $19.55 per share. Full sale price information for each lot is available to the Issuer's stockholders and the staff of the U.S. Securities and Exchange Commission upon their written request. The sales price reported herein is a weighted average price. These shares were sold in multiple lots at prices ranging from $19.69 to $19.93 per share. Full sale price information for each lot is available to the Issuer's stockholders and the staff of the U.S. Securities and Exchange Commission upon their written request. /s/ Jonathan Golightly, attorney-in-fact 2021-12-20